Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 10/20 | 0.50 |
| ▸ | MMP9 | P14780 | 10/20 | 0.50 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.47 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.46 |
| ▸ | MMP13 | P45452 | 5/20 | 0.44 |
| ▸ | MMP1 | P03956 | 4/20 | 0.44 |
| ▸ | MMP7 | P09237 | 3/20 | 0.44 |
| ▸ | MMP12 | P39900 | 3/20 | 0.44 |
| ▸ | ACE | P12821 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | MMP3 | P08254 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5120935 | 0.98 | MMP2 (0.49) | MMP2MMP9PSIP1HSD11B1MMP13 | |
| SCHEMBL8346448 | 0.85 | HSD11B1 (0.47) | MMP2MMP9PSIP1HSD11B1MMP13 | |
| SCHEMBL9570487 | 0.85 | MMP2 (0.52) | MMP2MMP9MMP13MMP1MMP7 | |
| SCHEMBL2810869 | 0.85 | PSIP1 (0.44) | MMP2MMP9PSIP1HSD11B1MMP13 | |
| SCHEMBL6683343 | 0.85 | MMP2 (0.68) | MMP2MMP9PSIP1HSD11B1MMP13 | |
| SCHEMBL7772552 | 0.85 | MMP2 (0.51) | MMP2MMP9 | |
| SCHEMBL6559430 | 0.85 | ATM (0.46) | MMP2MMP9PSIP1HSD11B1MMP13 | |
| SCHEMBL27911762 | 0.84 | MMP2 (0.70) | MMP2MMP9MMP13MMP1MMP7 | |
| Hydrochloric Acid SCHEMBL5124022 | 0.84 | PSIP1 (0.42) | MMP2MMP9PSIP1HSD11B1MMP13 | |
| SCHEMBL8346449 | 0.83 | PSIP1 (0.45) | MMP2MMP9PSIP1HSD11B1MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080161325-A1 | e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome | ELAN PHARMACEUTICALS, INC. | 2008-07-03 | — | — | US | claimed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| WO-2024073025-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
| CN-105319848-B | Colored curable resin composition | 住友化学株式会社 | 2021-03-26 | — | — | CN | disclosed |
| EP-2715416-B1 | COLORED RADIATION-SENSITIVE COMPOSITION FOR COLOR FILTER, PATTERN FORMING METHOD, COLOR FILTER AND METHOD OF PRODUCING THE SAME, AND SOLID-STATE IMAGE SENSOR | FUJIFILM CORP (JP) | 2019-10-30 | — | — | EP | disclosed |
| CN-102636957-B | Photosensitive composition and compound | 住友化学株式会社 | 2016-06-22 | — | — | CN | disclosed |
| US-9318522-B2 | Colored radiation-sensitive composition for color filter, pattern forming method, color filter and method of producing the same, and solid-state image sensor | FUJIFILM CORPORATION (JP) | 2016-04-19 | — | — | US | disclosed |
| CN-1308250-A | Photographic material, compound and method | EASTMAN KODAK CO (US) | 2001-08-15 | — | — | CN | disclosed |
| EP-1113006-A1 | Process for the synthesis of 2,5-dicarbonamidophenolic couplers and benzoxazole derivatives as intermediates | EASTMAN KODAK COMPANY (US) | 2001-07-04 | — | — | EP | disclosed |
| EP-1113328-A1 | Photographic element, compound, and process | EASTMAN KODAK COMPANY (US) | 2001-07-04 | — | — | EP | disclosed |
| US-6201125-B1 | REDUCING A 2-ALKYL-6-NITRO-BENZOXAZOLE TO FORM A 2-ALKYL-6-AMINO-BENZOXAZOLE IN WHICH THE 2-ALKYL GROUP IS UNBRANCHED AT THE ALPHA CARBON; COUPLERS | EASTMAN KODAK COMPANY | 2001-03-13 | — | — | US | disclosed |
| US-6197492-B1 | CYAN DYE HUE | EASTMAN KODAK COMPANY | 2001-03-06 | — | — | US | disclosed |
| US-6190850-B1 | CYAN ?NB COUPLER? THAT FORMS A DYE FOR WHICH THE LEFT BANDWIDTH (LBW) USING SPIN-COATING IS AT LEAST 5 NM LESS THAN THAT OF THE SAME DYE IN SOLUTION FORM | EASTMAN KODAK COMPANY | 2001-02-20 | — | — | US | disclosed |
| EP-0816308-A1 | Complexes containing tris(hydroxyalkyl)phosphines for telomerisations ans as catalysts | BAYER AG (DE) | 1998-01-07 | — | — | EP | disclosed |
| EP-0438994-B1 | Process for preparing sulfonyl acids | MONSANTO CO (US) | 1995-04-19 | — | — | EP | disclosed |
| EP-0438994-A1 | Process for preparing sulfonyl acids | Monsanto Company (US) | 1991-07-31 | — | — | EP | disclosed |
| US-4966731-A | Process for preparing sulfonyl acids | MONSANTO COMPANY (US) | 1990-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | MMP2 2699/4885MMP9 2004/4885PSIP1 941/4885 |
| US-20080161325-A1 | e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome | BACE1, APP, BACE2 | MMP2 1012/4885MMP9 1795/4885PSIP1 3167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.